Fingerprint
Dive into the research topics of 'HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically